Why the study?
Cardiac myxoma is the most frequent benign heart tumor and presents an important diagnostic challenge.
Case Report (n=1)
Cardiac myxomas can present atypically with intravascular hemolytic anemia and acute kidney injury, which may lead to irreversible renal failure if diagnosis is delayed.
Highlights risk of permanent dialysis in myxoma-associated hemolysis; leaves open role of earlier intervention.
Background: Cardiac myxoma is the most frequent “benign” tumor of the heart and presents an important diagnostic challenge. Case presentation: A 51-year-old woman was admitted at the hospital for anorexia, fatigue, nausea, and vomiting for the last 10 days. Laboratory results showed hemoglobin 5.26 g/dl, platelets 83× 10^9 μl, Lactate Dehydrogenase (LDH) 348 U/l, bilirubin 2.0 mg/dl, haptoglobin 100 mg/dl, negative Coombs test, blood smear with schistocytes and urea 327 mg/dl, creatinine 8.56 mg/dl. Non-autoimmune hemolytic anemia and acute kidney injury was assumed. After seven plasma exchange treatments, she went into acute pulmonary edema. Body tomography was performed, and revealed a mass in the left atrium. She underwent atriotomy and after surgery hemoglobin values stabilized but kidney function did not improve, and she became dialysis dependent. Conclusion: Myxomas can mimic other diseases which may delay diagnosis and compromise prognosis. In this particular case, the myxoma manifested with intravascular hemolytic anemia. This is an, especially, interesting case because a myxoma caused kidney failure without recovery.
No takes yet. Share an insight, caveat, or question.
Soares et al. (2020) conducted a case report in Cardiac myxoma (n=1). Cardiac myxoma was evaluated on Clinical recovery (hemoglobin and kidney function).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: